SECOND AMENDMENT TO L-018-2018/0Second Amendment • August 10th, 2020 • Forte Biosciences, Inc. • Pharmaceutical preparations
This is the second amendment (“Second Amendment”) of the agreement by and between the National Institute of Allergy and Infectious Diseases (“NIAID” or “IC”), and Forte Biosciences Inc, having an effective date of December 10, 2017 and having NIAID Reference Number L-018-2018/0 (“Agreement”). This Second Amendment, having NIAID Reference Number L‑018‑2018/2, is made between the NIAID through the Technology Transfer and Intellectual Property Office, NIAID, having an address at 5601 Fishers Lane, Suite 6D, Rockville, MD 20892-9804, and Forte Biosciences, having an address at [***]. This Second Amendment includes, in addition to the amendments made below, a Signature Page.
